- Home
- MLKN vs PRAX Comparison
MLKN vs PRAX Comparison
Compare MLKN & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLKN
- PRAX
- Stock Information
- Founded
- MLKN 1905
- PRAX 2015
- Country
- MLKN United States
- PRAX United States
- Employees
- MLKN N/A
- PRAX N/A
- Industry
- MLKN Office Equipment/Supplies/Services
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- MLKN Consumer Discretionary
- PRAX Health Care
- Exchange
- MLKN Nasdaq
- PRAX Nasdaq
- Market Cap
- MLKN 1.5B
- PRAX 1.4B
- IPO Year
- MLKN N/A
- PRAX 2020
- Fundamental
- Price
- MLKN $22.24
- PRAX $74.49
- Analyst Decision
- MLKN
- PRAX Strong Buy
- Analyst Count
- MLKN 0
- PRAX 9
- Target Price
- MLKN N/A
- PRAX $149.00
- AVG Volume (30 Days)
- MLKN 454.7K
- PRAX 388.8K
- Earning Date
- MLKN 03-26-2025
- PRAX 03-04-2025
- Dividend Yield
- MLKN 3.37%
- PRAX N/A
- EPS Growth
- MLKN 36.08
- PRAX N/A
- EPS
- MLKN 0.91
- PRAX N/A
- Revenue
- MLKN $3,593,100,000.00
- PRAX $1,605,000.00
- Revenue This Year
- MLKN $4.29
- PRAX N/A
- Revenue Next Year
- MLKN $4.62
- PRAX N/A
- P/E Ratio
- MLKN $24.55
- PRAX N/A
- Revenue Growth
- MLKN N/A
- PRAX N/A
- 52 Week Low
- MLKN $20.89
- PRAX $33.01
- 52 Week High
- MLKN $31.73
- PRAX $91.83
- Technical
- Relative Strength Index (RSI)
- MLKN 47.66
- PRAX 42.80
- Support Level
- MLKN $22.25
- PRAX $76.00
- Resistance Level
- MLKN $22.98
- PRAX $91.83
- Average True Range (ATR)
- MLKN 0.58
- PRAX 6.29
- MACD
- MLKN 0.08
- PRAX -1.10
- Stochastic Oscillator
- MLKN 58.88
- PRAX 2.42
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract , International Contract & Specialty International & Specialty and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.